REXAHN PHARMACEUTICALS, INC. 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Jan 14, 2014
Insider Transaction Report
Form 4
Jeong Tae Heum
DirectorCFO
Transactions
- Award
Stock Option (right to purchase)
2014-01-12+175,000→ 175,000 totalExercise: $1.14Exp: 2024-01-12→ Common Stock (175,000 underlying)
Holdings
- 505,000
Common Stock
- 250,000
Stock Option (right to purchase)
Exercise: $0.31Exp: 2023-03-01→ Common Stock (250,000 underlying) - 250,000
Stock Option (right to purchase)
Exercise: $0.78Exp: 2018-12-11→ Common Stock (250,000 underlying) - 500,000
Stock Option (right to purchase)
Exercise: $0.80Exp: 2015-01-20→ Common Stock (500,000 underlying)
Footnotes (4)
- [F1]Options will vest and be exercisable based on the following schedule: 52,500 on January 12, 2015, 52,500 on January 12, 2016, and 70,000 on January 12, 2017.
- [F2]Options will vest and be exercisable based on the following schedule: 75,000 on March 1, 2014, 75,000 on March 1, 2015, and 100,000 on March 1, 2016.
- [F3]Options vested and became exercisable based on the following schedule 75,000 on December 11, 2009, 75,000 on December 11, 2010, and 100,000 on December 11, 2011.
- [F4]Options vested and became exercisable based on the following schedule 150,000 on January 20, 2006, 150,000 on January 20, 2007, and 200,000 on January 20, 2008.